Amazon.com and Jeff Bezos Talk Long Term and Mean It
In 1997, the year Amazon.com went public, its chief executive, Jeff Bezos, issued a manifesto: “It's all about the long term,” he said. He warned shareholders “we may make decisions and weigh tradeoffs differently than some companies” …
Context & Ripple Effects
The New York Times' year-end profile lands on a doctrine Jeff Bezos has been stating since Amazon's 1997 shareholder letter, which warned investors the company would 'weigh tradeoffs differently than some companies.' Earlier in 2011 he gave the same idea its sharpest phrasing yet, telling the Seattle shareholder meeting that Amazon is willing to be misunderstood for long periods of time while it pursues innovation.
Seventeen years after founding, Amazon employs nearly 40,000 people, and the profile's argument is that the long-term rhetoric is operational rather than ornamental — thin reported profits coexisting with heavy reinvestment. With no rival coverage or public reaction recorded around publication, the piece functions less as news than as a canonical restatement of the strategy at scale.
First-order effects
- Investors holding Amazon stock through 2011 get an explicit signal that near-term margins will stay subordinate to reinvestment, keeping pressure on earnings-based valuation models of the company.
- Bezos's public framing hands Amazon's management standing room with shareholders: sustained low profitability can be presented as doctrine rather than underperformance.
Second-order effects
- Retail and e-commerce competitors must either match Amazon's investment-and-price posture from thinner capital bases or cede ground, since a rival that accepts years of thin returns resets what customers expect on price and delivery.
- Wall Street's analyst community faces a recurring modeling problem — a mega-cap whose guidance explicitly discounts quarterly optics — pushing coverage toward cash flow and market-share metrics instead of earnings.
Third-order effects
- If the pattern holds, Amazon becomes the template for founder-led companies raising patient capital against decade-long horizons, making tolerance for prolonged profitlessness a deliberate competitive instrument rather than a distress signal.
- That template raises a structural governance question for markets: whether public-company disclosure norms built around quarterly earnings can accommodate firms that openly optimize on longer clocks.
The trend: Patient-capital discipline — accepting years of misunderstood financials to compound infrastructure advantages — is emerging as a defining strategic weapon of scaled technology companies.